Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$83.14 - $145.99 $119,971 - $210,663
-1,443 Reduced 12.36%
10,230 $1.49 Million
Q1 2022

May 16, 2022

BUY
$110.08 - $142.92 $1.28 Million - $1.67 Million
11,673 New
11,673 $1.38 Million
Q4 2021

Feb 14, 2022

SELL
$99.73 - $148.48 $1.29 Million - $1.92 Million
-12,927 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$98.85 - $138.91 $739,991 - $1.04 Million
7,486 Added 137.59%
12,927 $1.8 Million
Q2 2021

Aug 16, 2021

BUY
$65.78 - $105.02 $357,908 - $571,413
5,441 New
5,441 $528,000
Q4 2020

Feb 16, 2021

SELL
$65.07 - $98.24 $896,274 - $1.35 Million
-13,774 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$59.04 - $77.95 $813,216 - $1.07 Million
13,774 New
13,774 $895,000
Q2 2020

Aug 14, 2020

SELL
$29.01 - $74.23 $586,379 - $1.5 Million
-20,213 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$27.51 - $57.29 $495,620 - $1.03 Million
-18,016 Reduced 47.13%
20,213 $688,000
Q4 2019

Feb 14, 2020

BUY
$40.86 - $57.65 $364,348 - $514,065
8,917 Added 30.42%
38,229 $2.08 Million
Q3 2019

Nov 14, 2019

SELL
$37.38 - $49.47 $1.18 Million - $1.56 Million
-31,512 Reduced 51.81%
29,312 $1.22 Million
Q2 2019

Aug 14, 2019

SELL
$39.79 - $67.01 $818,758 - $1.38 Million
-20,577 Reduced 25.28%
60,824 $2.66 Million
Q1 2019

May 15, 2019

BUY
$34.52 - $53.29 $890,616 - $1.37 Million
25,800 Added 46.4%
81,401 $4.19 Million
Q4 2018

Feb 14, 2019

BUY
$29.75 - $42.9 $22,163 - $31,960
745 Added 1.36%
55,601 $2.06 Million
Q3 2018

Nov 14, 2018

BUY
$32.79 - $43.0 $1.32 Million - $1.73 Million
40,256 Added 275.73%
54,856 $2.06 Million
Q2 2018

Aug 14, 2018

BUY
$23.62 - $42.29 $106,290 - $190,305
4,500 Added 44.55%
14,600 $577,000
Q1 2018

May 15, 2018

SELL
$22.49 - $34.56 $257,847 - $396,230
-11,465 Reduced 53.16%
10,100 $260,000
Q4 2017

Feb 14, 2018

BUY
$20.44 - $35.56 $440,788 - $766,851
21,565
21,565 $582,000

Others Institutions Holding BHVN

About Biohaven Pharmaceutical Holding Co Ltd.


  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.65B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.